Picture of AnaptysBio logo

ANABV — AnaptysBio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapHigh Flyer

Brief: Anaptys To Receive $50 Mln In Capped Non-Recourse Monetization From Amended Agreement With Sagard In Exchange For Additional Jemperli Royalties

May 9 (Reuters) - AnaptysBio Inc  ANAB.O :
    * ANAPTYS TO RECEIVE $50 MILLION IN A CAPPED NON-RECOURSE
MONETIZATION FROM AMENDED AGREEMENT WITH SAGARD IN EXCHANGE FOR
ADDITIONAL JEMPERLI ROYALTIES

Source text for Eikon:  ID:nGNXgmfQL 
Further company coverage:  ANAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on AnaptysBio

See all news